
IQVIA Holdings Inc.
IQVIA Holdings Inc. (IQV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IQV · as of Jun 8, 2026
Key Statistics
Explore IQVIA Holdings Inc. Data
iqv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 44 · Buy rate: 84.1%
The IQV analyst consensus is Buy, based on ratings from 44 Wall Street analysts over the past 3 months. The average 12-month price target is $222.22, representing +21.13% upside from the current price of $183.45.
Competitors & Peers
iqv competitorsStock Performance
Full HistoryAbout IQVIA Holdings Inc.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates t…
what is iqvia holdings inc. · iqv stock overview · iqvia holdings inc. company profile · who is iqvia holdings inc. ceo · iqv NYSE · iqvia holdings inc. headquarters · iqvia holdings inc. business segments
About Stock Overview & Key Data
IQVIA Holdings Inc. (IQV) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NYSE since May 9, 2013. As of the latest trading session, IQV stock price is $183.45, with a market capitalization of $30.6B. The stock has returned +19.01% over the past 12 months and -18.61% year-to-date.
According to 44 Wall Street analysts, the consensus rating for IQVIA Holdings Inc. stock is Buy, with an average 12-month price target of $222.22. In fiscal year 2025, IQVIA Holdings Inc. reported revenue of $16.3B and net income of $1.4B. For detailed data — including IQVIA Holdings Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IQVIA Holdings Inc. (IQV) stock price is $183.45. The stock is traded on NYSE under the ticker symbol IQV. The 52-week range is $146.44 – $247.05.